Unknown

Dataset Information

0

C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation


ABSTRACT: Intronic GGGGCC (G4C2) hexanucleotide repeat expansion within the human C9orf72 gene represents the most common cause of familial forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9ALS/FTD). Repeat-associated non-AUG (RAN) translation of repeat-containing C9orf72 RNA results in production of neurotoxic dipeptide-repeat proteins (DPRs). Here, we developed a high-throughput drug screen for the identification of positive and negative modulators of DPR levels. We found that HSP90 inhibitor geldanamycin and aldosterone antagonist spironolactone reduced DPR levels by promoting protein degradation via the proteasome and autophagy pathways, respectively. Surprisingly, cAMP-elevating compounds boosting protein kinase A (PKA) activity increased DPR levels. Inhibition of PKA activity, by both pharmacological and genetic approaches, reduced DPR levels in cells and rescued pathological phenotypes in a Drosophila model of C9ALS/FTD. Moreover, knockdown of PKA-catalytic subunits correlated with reduced translation efficiency of DPRs, while the PKA inhibitor H89 reduced endogenous DPR levels in C9ALS/FTD patient-derived iPSC motor neurons. Together, our results suggest new and druggable pathways modulating DPR levels in C9ALS/FTD.

SUBMITTER: Dr. Nausicaa, Valentina Licata 

PROVIDER: S-SCDT-EMBOJ-2020-105026 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8724771 | biostudies-literature
| S-EPMC7041170 | biostudies-literature
| S-EPMC7451925 | biostudies-literature
| S-EPMC5078984 | biostudies-literature
| S-EPMC4552077 | biostudies-literature
| S-EPMC5764992 | biostudies-literature
| S-EPMC5653973 | biostudies-literature
| S-EPMC10541178 | biostudies-literature
| S-EPMC4589299 | biostudies-literature
2015-09-11 | E-GEOD-72771 | biostudies-arrayexpress